Kisqali Can Help Treat Younger Women W/ Metastatic HR+ Disease

Options
Moderators
Moderators Member Posts: 25,912

Kisqali Can Help Treat Younger Women With Metastatic Hormone-Receptor-Positive Disease
December 19, 2017

Kisqali along with either an aromatase inhibitor or tamoxifen and medicine to suppress ovarian function offers better progression-free survival than just hormonal therapy and ovarian suppression in premenopausal women with advanced-stage, hormone-receptor-positive, HER2-negative disease. Read more...

Categories